Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer. [electronic resource]
Producer: 20130510Description: 313-20 p. digitalISSN:- 1532-1967
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Breast Neoplasms -- drug therapy
- Clinical Trials as Topic
- Female
- Humans
- Molecular Targeted Therapy -- methods
- Oncogene Protein v-akt -- antagonists & inhibitors
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- administration & dosage
- Signal Transduction -- drug effects
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.